Chinese biotech firm Gracell nets $100m from Wellington, OrbiMed, others

Chinese biotech firm Gracell nets $100m from Wellington, OrbiMed, others

Photo by Dmitry Bayer on Unsplash

29 October, 2020

5Y Capital Gracell Biotechnologies Inc OrbiMed Healthcare Fund Management Wellington Management

Printed by Unregistered user on Tue, 29 Jul 2025 18:15:05 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Temasek leads $85m Series B round for China-based Gracell Biotech

Wellington Management closes Biomedical Innovation Fund at $393m

Read more from Greater China

Policy & Regulations

US, China end tariff talks in Stockholm as truce holds for now

Policy & Regulations

Hong Kong may issue first stablecoin licences early next year